Does ATEZOLIZUMAB Cause Endocarditis staphylococcal? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Endocarditis staphylococcal have been filed in association with ATEZOLIZUMAB (Tecentriq Hybreza). This represents 0.0% of all adverse event reports for ATEZOLIZUMAB.
6
Reports of Endocarditis staphylococcal with ATEZOLIZUMAB
0.0%
of all ATEZOLIZUMAB reports
6
Deaths
0
Hospitalizations
How Dangerous Is Endocarditis staphylococcal From ATEZOLIZUMAB?
Of the 6 reports, 6 (100.0%) resulted in death.
Is Endocarditis staphylococcal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATEZOLIZUMAB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does ATEZOLIZUMAB Cause?
Death (3,591)
Off label use (2,340)
Disease progression (1,828)
Pyrexia (1,599)
Diarrhoea (1,490)
Fatigue (1,253)
Anaemia (1,195)
Pneumonia (1,036)
Nausea (953)
Dyspnoea (938)
What Other Drugs Cause Endocarditis staphylococcal?
PREDNISONE (31)
TACROLIMUS (23)
BUPRENORPHINE (22)
RITUXIMAB (21)
VANCOMYCIN (20)
DAPTOMYCIN (16)
PREDNISOLONE (15)
METHOTREXATE (12)
ADALIMUMAB (11)
MYCOPHENOLATE MOFETIL (11)
Which ATEZOLIZUMAB Alternatives Have Lower Endocarditis staphylococcal Risk?
ATEZOLIZUMAB vs ATLANTIC SALMON OIL
ATEZOLIZUMAB vs ATOGEPANT
ATEZOLIZUMAB vs ATOMOXETINE
ATEZOLIZUMAB vs ATOMOXETINE\ATOMOXETINE
ATEZOLIZUMAB vs ATORVASTATIN